【中新健康】专家最新研究：脑出血者发病2小时内强化降压治疗致残致死风险减少25%
中新网上海5月20日电 (记者 陈静)脑出血是脑卒中的一种严重类型，其致残和致死风险一直受到广泛关注。20日，中国医学专家的最新研究结果为脑出血患者的治疗带来了新的希望。研究明确了“脑出血强化降压2小时治疗时间窗”，即在发病2小时内启动强化降压治疗，将收缩压降至130-140mmHg，可显著减少25%的致残致死风险。
该项研究由中国多家知名医疗机构的专家团队共同完成，研究对象为出血性脑卒中患者。研究结果显示，早期强化降压治疗对于脑出血患者具有重要意义。在发病后的黄金2小时内，及时将收缩压降至130-140mmHg，可以有效降低患者的致残和致死风险，这对于改善患者的预后具有显著的临床价值。
专家表示，这一研究成果填补了国内外在该领域的空白，为脑出血患者的治疗提供了明确的指导。过去，由于缺乏针对脑出血强化降压治疗的明确指南，许多患者错过了最佳治疗时机，导致预后不良。如今，医学专家们通过大量临床研究，明确了脑出血强化降压治疗的时间窗，这对于提高脑出血患者的生存质量和生存率具有重要意义。
据悉，该项研究已引起国内外医学界的广泛关注，被视为脑出血治疗领域的重大突破。未来，这一研究成果将有望被写入国内外脑出血治疗指南，为更多脑出血患者带来生的希望。
脑出血是脑卒中的一种严重类型，其致残和致死风险一直受到广泛关注。20日，中国医学专家的最新研究结果为脑出血患者的治疗带来了新的希望。研究明确了“脑出血强化降压2小时治疗时间窗”，即在发病2小时内启动强化降压治疗，将收缩压降至130-140mmHg，可显著减少25%的致残致死风险。
该项研究由中国多家知名医疗机构的专家团队共同完成，研究对象为出血性脑卒中患者。研究结果显示，早期强化降压治疗对于脑出血患者具有重要意义。在发病后的黄金2小时内，及时将收缩压降至130-140mmHg，可以有效降低患者的致残和致死风险，这对于改善患者的预后具有显著的临床价值。
专家表示，这一研究成果填补了国内外在该领域的空白，为脑出血患者的治疗提供了明确的指导。过去，由于缺乏针对脑出血强化降压治疗的明确指南，许多患者错过了最佳治疗时机，导致预后不良。如今，医学专家们通过大量临床研究，明确了脑出血强化降压治疗的时间窗，这对于提高脑出血患者的生存质量和生存率具有重要意义。
据悉，该项研究已引起国内外医学界的广泛关注，被视为脑出血治疗领域的重大突破。未来，这一研究成果将有望被写入国内外脑出血治疗指南，为更多脑出血患者带来生的希望。
英语如下：
**Title:** Expert Study: Intensified Blood Pressure Lowering Within 2 Hours of Brain Hemorrhage Can Reduce Disability and Mortality Risk by 25%
**Keywords:** Brain Hemorrhage, Intensified Blood Pressure Lowering, Risk Reduction
**News Content:**
[‘China News Health’](#) Expert latest study: Brain hemorrhage patients have a 25% reduced risk of disability and mortality when treated with intensified blood pressure lowering within 2 hours of onset.
SHANGHAI, May 20 (XinhuaNet) — (Reporter Chen Jing) Brain hemorrhage, a severe type of stroke, has always been a major concern due to its high risk of disability and mortality. On May 20th, the latest research results from Chinese medical experts provided new hope for the treatment of brain hemorrhage patients. The study has identified a “2-hour treatment window for intensified blood pressure lowering in brain hemorrhage,” which means starting intensified blood pressure lowering treatment within 2 hours of the onset, and bringing down the systolic blood pressure to 130-140mmHg, can significantly reduce the risk of disability and mortality by 25%.
This study was jointly completed by a team of experts from several well-known medical institutions in China, focusing on patients with hemorrhagic strokes. The results showed that early intensified blood pressure lowering treatment is of great significance for patients with brain hemorrhage. Within the critical 2-hour period after onset, promptly lowering the systolic blood pressure to 130-140mmHg can effectively reduce the risk of disability and mortality in patients, which has significant clinical value for improving patient outcomes.
Experts indicated that this research fills a gap both domestically and internationally and provides clear guidance for the treatment of brain hemorrhage. In the past, due to the lack of clear guidelines for intensified blood pressure lowering treatment in brain hemorrhage, many patients missed the best treatment time, leading to poor prognosis. Now, medical experts have clarified the time window for intensified blood pressure lowering treatment in brain hemorrhage through extensive clinical research, which is of great significance for improving the quality and survival rate of patients with brain hemorrhage.
It is understood that this study has attracted widespread attention from the medical community at home and abroad and is considered a significant breakthrough in the treatment of brain hemorrhage. In the future, this research achievement is expected to be included in the treatment guidelines for brain hemorrhage both domestically and internationally, bringing new hope for life to more brain hemorrhage patients.
【来源】http://www.chinanews.com/sh/2024/05-20/10220312.shtml
Views: 2